Establishment of a Prognostic Prediction and Drug Selection Model for Patients with Clear Cell Renal Cell Carcinoma by Multiomics Data Analysis

Figure 9

Construction of the risk scores. (a–d) ROC curve of OS and PFI, as well as Kaplan-Meier survival curve of OS and PFI of the two identified subtypes of renal cancer in train cohort. (e–h) ROC curve of OS and PFI, as well as Kaplan-Meier survival curve of OS and PFI of the two identified subtypes of renal cancer in train cohort.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)